InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,035.69
(
-1.57%
)
US TECH 100
16,926.80
(
-2.21%
)
Dow Jones
37,815.92
(
-1.49%
)
Brent Oil
85.55
(
-0.41%
)
Bitcoin
59,960.01
(
-1.04%
)
Post# of 251654
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

WorstLuck

Send PM Follow Ignore
Followers 9
Posts 985
Boards Moderated 0
Alias Born 02/23/2010

WorstLuck

Re: DewDiligence post# 183018

Tuesday, 10/21/2014 10:56:04 AM

Tuesday, October 21, 2014 10:56:04 AM

Post# of 251654
Currently that would be the case.

I have not seen where your model has been updated to reflect the NVS partnered drug being returned, hence the exclusion is pertinent.

As to your other points, reasonable people can disagree. Thanks to your structured case it was fairly simple to present my own changes using that general structure that all can follow. I don't have any claim as a biotech analyst.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up